INTRODUCTION

Serum 25-hydroxyvitamin D [25(OH)D]
is the accepted biomarker of vitamin D exposure. One approach to the determination of the sufficiency of vitamin D for bone health outcomes has been to seek the serum concentration of 25(OH)D that would prevent a rise in the parathyroid hormone (PTH) concentration (1, 2) . Another approach has been to seek the concentration of serum 25(OH)D that maximizes intestinal calcium absorption (3, 4) . These approaches are based on the inferred prevention of bone loss from secondary hyperparathyroidism in the first case and on maximizing intestinal absorption of calcium in the second case.
Malabsorption of calcium in rickets was reported .80 y ago and was confirmed in several recent studies at serum 25(OH)D concentrations below 10-12 nmol/L (5, 6) . Optimal serum 25(OH)D concentrations to maintain bone health and prevent osteoporosis are believed to be higher than the low concentrations needed to prevent rickets and osteomalacia. There is active debate over what these concentrations should be, and expert opinion has suggested that they should be either 50-65 or .75 nmol/L (5, 7). The attainment of each of these 25(OH)D concentrations in the general population requires substantially different intakes of vitamin D.
There is controversy over the concentration of serum 25(OH)D that suppresses PTH (8, 9) . There has also been recent controversy concerning whether the relation between serum 25(OH)D concentrations and maximal calcium absorption efficiency may be useful as an indicator of vitamin D sufficiency. Heaney (10) reviewed evidence that a concentration of serum 25(OH)D of 75-80 nmol/L reflects the inflection for maximal calcium absorption efficiency in response to increasing serum 25(OH)D concentrations. However, Need and Nordin (11) challenged the concept that calcium absorption is related to serum 25(OH)D at concentrations above those associated with osteomalacia.
Because the relation of calcium absorption to serum 25(OH)D concentrations has been used to propose optimal vitamin D intake, we reanalyzed the data from a previously reported study in which we measured concentrations of serum 25(OH)D, 1,25(OH) 2 D and PTH and calcium absorption efficiency in almost 500 healthy women (12) . We wished to explore whether intestinal calcium absorption was related to either serum 25(OH)D or 1,25(OH) 2 D concentrations and whether there was an interaction between the concentrations of these vitamin D metabolites.
SUBJECTS AND METHODS
The data reported in the present study analyses are from a previously reported study of body composition and calcium metabolism in 503 healthy black and white women aged 20-80 y (12) . A total of 492 participants had calcium absorption mea-sured. The study was carried out between February 1991 and November 1994.
Participants
Participants were recruited through advertisements in the local media and a direct mail campaign. Exclusion characteristics consisted of any chronic illness, medication know to affect bone metabolism, use of oral contraceptives, hormonal replacement therapy, or hysterectomy. The study was approved by the Institutional Review Board of Winthrop University Hospital, and written informed consent was obtained from each participant. A 3-d diet history was completed and reviewed with the study dietitian. A body mass index (in kg/m 2 ) of 18-33 was considered acceptable for inclusion in the study.
Calcium absorption
Calcium absorption efficiency was based on a single measurement of serum specific activity after administration of an oral calcium tracer by using the method of Heaney and Recker (13 
Statistical analyses
Correlation analyses were used to estimate associations among relevant variables. Multiple linear regression analyses were used to model the calcium absorption to predictive factors. A regression model that included all significant predictors was chosen as the main effect model. The interaction between 25(OH)D and 1,25(OH) 2 D was tested by adding an interaction term of 25(OH)D · 1,25(OH) 2 D to the main effect model (17) . We standardized all variables (all variables had a standardized score of 0 6 1 [mean 6 SD]), which avoided multicollinearity on testing interactions and produced estimates of effects of predictors that could be compared directly and most readily interpreted as standardized mean differences (17) .
The sample was based on 492 participants who had calcium absorption measured. Seven variables had missing data. Missing values among potential predictors were addressed by using multiple imputation (18) to avoid the possible estimate bias and to maximize our sample size and power for interaction testing (17) .
Multiple imputation was applied to the 7 variables that had incomplete data by using the other observed variables to impute the missing data. Missing data were replaced by random draws from a distribution of plausible values with SAS Proc MI (SAS Institute, Cary, NC) (19) to create 5 imputed data sets. Each imputed data set was analyzed separately. The findings from these analyses were summarized with SAS Proc MIANALYZE (SAS Institute) to combine the uncertainty in the estimated variables within and across the 5 imputed data sets (19) .
On the basis of a total sample size of 492, we had 3, 4, 5, 9, 9, and 37 cases with missing values for concentrations of serum creatinine, PTH, 1,25(OH) 2 D, serum estradiol, and 25(OH)D and calcium intake, respectively. We only had n = 430 with complete data when we put all of these variables in the same model for selecting the final model. Analyses that compared the imputed dataset with the complete dataset showed no significant difference in regression coefficients. Moreover, the SEs for imputed data were smaller than the SEs for the completer data, which indicated that the imputation procedure was successful in recovering part of the missing information. We report findings from both complete data and imputed data. Demographic characteristics and the distribution (mean 6 SD) of biochemical variables are given in Table 1 . There were 146 black and 126 white premenopausal participants and 84 black and 136 white postmenopausal participants. Serum calcium concentrations were in the reference range for all participants.
Model selection for calcium absorption using relevant covariates for selecting the best predictive model
The data were used to build a predictive model to relate calcium absorption to other measured covariates (Tables 2 and 3) . A multiple regression approach was used for this modeling, and a stepwise model selection was used to statistically select the best predictors. The most significant variables related to calcium absorption were menopausal status, calcium intake, and serum estradiol and serum 1,25(OH) 2 D concentrations. There was an interaction between 25(OH)D and 1,25(OH) 2 D ( Table 4) .
Model selection for PTH
The following variables significantly related to serum PTH concentrations in our final model ( 2 Premenopausal was coded 0, and postmenopausal was coded 1.
3 Black race was coded 0, and white race was coded 1. PTH concentrations, calcium absorption, serum creatinine concentrations, bone mineral density, and race. Calcium absorption as a function of serum 1,25(OH) 2 D concentrations had a lower intercept (z score) in postmenopausal women [20. 369 (P , 0.0001)] than in premenopausal women [0.295 (P , 0.0001)]. The slopes were 0.121 (P , 0.05) and 0.174 (P , 0.01) for premenopausal and postmenopausal women after adjusting for other significant predictors (Figures 1 and 2) . The regression coefficients of age on PTH, 1,25(OH) 2 D, and calcium absorption were 20.044 (P = 0.335), 0.056 (P = 0.213), and 20.318 (P , 0.001), respectively. The regression coefficient of menopausal status on calcium absorption was 20.647 (P , 0.0001). For the final model of calcium absorption, we only used menopausal status to avoid collinearity between age and menopausal status because r between them was .0.8.
Interaction of 25(OH)D and 1,25(OH) 2 D with calcium absorption
We observed that there was no statistically significant relation (r = 20.085; P = 0.06) between serum 25(OH)D and calcium absorption efficiency in the entire sample. The correlation between serum 25(OH)D and 1,25(OH) 2 D concentrations was 20.048 (P = 0.29), which was also not significant. The interaction (regression coefficient = 20.074; P = 0.048) between 25(OH)D and 1,25(OH) 2 D was significant for imputed data (regression coefficient = 20.074; P = 0.048) and marginally significant for complete data (regression coefficient = 20.070; P = 0.089) ( Table 4 ). The relation between calcium absorption and 1,25(OH) 2 D was positive, and this relation was stronger for low concentrations of 25(OH)D than it was for high concentrations of 25(OH)D.
DISCUSSION
We observed no relation between serum 25(OH)D concentrations and calcium absorption efficiency in a large sample of healthy women over a wide age range. On the basis of this finding, calcium absorption efficiency was not useful as an indicator for vitamin D sufficiency.
A review article by Heaney (10) presented a widely cited graph that purported to show that calcium absorption rose progressively with an increasing serum 25(OH)D concentration until a plateau (threshold) was reached at 80 nmol/L. The conclusions in this article have been promulgated to suggest that serum 25(OH)D concentrations influence calcium absorption and optimal 25(OH)D concentrations are above this threshold. However, analyses of the individual studies that composed the graph and the construction of the graph made it clear that these conclusions were not justified. The lowest point on the graph was derived from a study that did not measure calcium absorption by either calcium loading or the use of radioisotopes. Indeed, the value was based on urinary calcium (5, 20) . Two of the other points (50 and 86 nmol/L were taken from studies (21, 22) that used the calcemic response to a 500-mg calcium load rather than the measurement of fractional calcium absorption. The remaining 2 points in the graph were from studies that did measure fractional calcium absorption by using the single-isotope technique. The difference between these 2 points (74 and 122 nmol/L) was not significant (23) . Thus, by using the 2 graph points that were not questionable, there is little evidence for a threshold. Therefore, this analysis of published studies may be considered hypothesis-generating.
The measurement of calcium absorption by using isotopes may be influenced by several methodologic issues. A low-carrier load is more sensitive to early transcellular transport and is favored by some investigators (24) . Other investigators give the tracer with a small meal at breakfast. Double-tracer methods allow for correction of calcium body pools. In single-tracer studies, either stool is collected or mathematical corrections are made for determinations of calcium body pools. The dual-isotope method is considered the gold standard. The protocol used for this study (a high carrier and single isotope) is useful for large studies of groups (25) .
A large study conducted by Need and Nordin (11) Several studies that used double isotopes also showed no relation between 25(OH)D concentrations and calcium absorption in children and adolescents (26, 27) . Recently, Hansen et al (28) measured fractional calcium absorption in 18 postmenopausal women before and after repletion. The mean 25(OH)D concentration at baseline was 52.5 nmol/L, and all women had postergocalciferol concentrations .87.5 nmol/L (mean: 160 nmol/L). The increase in fractional calcium absorption was only 3%, which may not be clinically significant. Furthermore, a recent randomized controlled trial with an intervention of 1000 IU vitamin D 2 /d (and an achieved mean serum 25(OH)D .100 nmol/L) showed no effect on calcium absorption (29) . Importantly, this was a long-term study that performed low-and highcarrier absorption studies.
The interactions we observed in our population were consistent with the known physiology of the vitamin D-endocrine system. We observed the previously reported inverse relation of 25 Menopausal status (and estradiol concentrations) was a major influence on calcium absorption in this study (r = 20.647; P , 0.0001), which obscured the effect of age (r = 20.318; P , 0.001). Estrogen deficiency (and, therefore, menopause) lowers intestinal calcium absorption and is corrected by the administration of exogenous estrogen (31) (32) (33) . The suggestion that there is intestinal resistance to calcitriol in estrogen deficiency is supported by our finding that calcium absorption was a function of serum calcitriol in pre-and postmenopausal groups but had a lower intercept in the postmenopausal women (34) .
A single isotope with a test breakfast was used in our study, in accordance with the protocol described by Heaney and Recker (13) . This protocol is a modification of a single-isotope method that is conducted with a low-carrier load (24) . The high carrier moves more slowly throughout the small intestine and may be conceived as measuring a succession of isotope blood curves. Heaney and Recker (13) chose the 5-h point to reduce the variation in completeness of absorption, but this was a compromise with the variation in the pool turnover rate. Despite these limitations, the single isotope method in our study showed a relation to calcium absorption for 1,25(OH)2D but not for 25(OH)D.
In conclusion, we did not find a relation between serum 25(OH)D concentrations and calcium absorption in a multiethnic cross-sectional study conducted in almost 500 healthy women over a wide age range. We conclude that the relation of serum 25(OH)D concentrations to calcium absorption cannot be used as a biomarker for vitamin D sufficiency.
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